The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

The study presented in this article used a controlled-porosity osmotic pump, which was prepared in the form of a bilayered tablet containing a drug compartment and an osmogen layer for the delayed release of diltiazem HCI.

External Link - article-70094.pdf

Articles in this issue

almost 23 years ago

Article

September 2003

almost 23 years ago

Article

In the Spotlight September 2003

almost 23 years ago

Article

Counterfeiting, Compliance, and Controls

almost 23 years ago

Article

September 2003

almost 23 years ago

Article

Disposable Filtration Lightens Cleaning and Validation Load

almost 23 years ago

Article

CROs Hoping for Research Burst in Second Half of 2003

almost 23 years ago

Article

Positron Emission Particle Tracking Studies of a Wurster Process for Coating Applications

almost 23 years ago

Article

Improved Blister Packaging Benefits Consumers, Caregivers, and Drug Makers

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.